Chapters

Transcript

Video

What specific, actionable signals emerged from results of Part C of the ARTISTRY-1 trial with respect to partial/complete and/or enduring responses employing a combination of the cytokine fusion protein nemvaleukin in combination with ICIs?


Created by

CMEducation Resources | iQ&A Cytokine Immunotherapy Intelligence Zone

Presenter

Ulka Vaishampayan, MBBS

Ulka Vaishampayan, MBBS

Professor of Internal MedicineDirector, Phase I ProgramRogel Cancer CenterUniversity of MichiganAnn Arbor, MI